Sign in

LabelSignal Flow

AI workflow engine that helps scientists access and orchestrate advanced drug discovery tools within label signal intelligence and pharmacovigilance workflows.

The Problem

“Accelerate and de-risk safety labeling decisions with AI-assisted label signal intelligence”

Organizations face these key challenges:

1

Regulatory reviewers cannot manually inspect every line of every labeling change efficiently

2

Safety evidence is fragmented across spontaneous reports, literature, internal analyses, and prior label history

3

Pediatric postmarketing surveillance signals are noisy and difficult to interpret

4

Teams lack real-time visibility into label-change progress and bottlenecks

5

eCTD publishing is labor-intensive and error-prone

6

Decision rationales are inconsistently documented across reviewers and products

7

Human experts spend too much time on low-value document handling instead of scientific judgment

8

Maintaining compliance, traceability, and approval controls slows automation efforts

Impact When Solved

Reduce time spent triaging safety-related labeling changesCompress safety signal to labeling decision and submission timelinesImprove consistency of reviewer-assisted regulatory validationCreate traceable evidence chains for audit and inspection readinessAutomate eCTD document assembly and status monitoringSupport pediatric postmarketing evidence synthesis with human oversightLower operational burden on pharmacovigilance and labeling teams

The Shift

Before AI~85% Manual

Human Does

  • •Define the investigation question and identify needed analyses
  • •Navigate multiple tools and data sources to gather inputs
  • •Request specialized workflow runs or manually execute approved steps
  • •Review outputs, reconcile findings, and document conclusions

Automation

  • •Run predefined analytics within individual tools
  • •Return tool-specific outputs and reports
  • •Store data and results in separate systems
With AI~75% Automated

Human Does

  • •State the investigation objective and confirm workflow scope
  • •Review AI-recommended workflow steps and approve execution
  • •Interpret scientific significance of results and make label-signal decisions

AI Handles

  • •Translate natural-language requests into approved workflow plans
  • •Retrieve relevant context from prior investigations, SOPs, and label histories
  • •Launch and coordinate multi-step analyses across discovery and safety tools
  • •Monitor execution, validate outputs, and flag issues for review

Operating Intelligence

How LabelSignal Flow runs once it is live

AI runs the operating engine in real time.

Humans govern policy and overrides.

Measured outcomes feed the optimization loop.

Confidence92%
ArchetypeOptimize & Orchestrate
Shape6-step circular
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapecircular

Step 1

Sense

Step 2

Optimize

Step 3

Coordinate

Step 4

Govern

Step 5

Execute

Step 6

Measure

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6↺ Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI senses, optimizes, and coordinates in real time. Humans set policy and override when needed. Measurements close the loop.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in LabelSignal Flow implementations:

Drug Safety-Related Labeling Changes databaseOther
4 mentions
Excel results exportOther
4 mentions
Predefined six-category adjudication schemeOther
4 mentions
LabelComp comparison toolOther
3 mentions
Side-by-side label text viewerOther
3 mentions
+1 more technologies(sign up to see all)

Key Players

Companies actively working on LabelSignal Flow solutions:

fully manual FDA label review workflowstraditional pharmacovigilance review processes

Real-World Use Cases

Reviewer-assisted regulatory validation workflow for safety-related labeling changes

The AI does the first pass on two versions of a drug label, and human reviewers check the highlighted changes to confirm whether they are real new safety issues.

human-in-the-loop decision supportoperationally plausible human-in-the-loop workflow demonstrated in validation, but still dependent on expert review.
10.0

Labeling-change decision support from pediatric postmarketing surveillance

After checking child safety reports for Lialda, FDA uses the findings to decide whether the medicine’s warning label needs new side effects added or whether routine monitoring is enough.

evidence synthesis and decision supportdeployed regulatory decision workflow
10.0

Label-maintenance decision support from pediatric postmarketing surveillance

FDA used the safety-review workflow to decide whether Entresto's pediatric warning label needed changes, and the reviewed data did not show a new problem.

evidence synthesis for decision supportdeployed regulatory decision-support workflow with clear downstream action on labeling assessment.
10.0

Real-time dashboards and eCTD publishing to compress safety-to-label cycle

Managers can see where every label change sits, and the system can publish submission packages directly, removing weeks of manual document assembly.

process monitoring and automationoperationally mature for workflow monitoring and publishing, though vendor-public metrics are limited.
10.0

Free access to this report